Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8659230 | EJVES Short Reports | 2017 | 4 Pages |
Abstract
Initial VAS was 8.8 ± 1.3 points and at the twelfth cleaning VAS was 0.8 ± 1 points (p = .001). Latency time ranged between 2 and 7 m and duration ranged between 8 and 18 h. It improved quality of life (83 ± 14 points before treatment vs. 50 ± 14 at the twelfth cleaning) and functional capacity (82 ± 13.3 before treatment vs. 91 ± 11.6 points at the twelfth cleaning) (p = .001). The safety profile was favourable with mild and self limited local cutaneous adverse effects, including pruritus, erythema, and heat. No systemic toxicity was detected. Topical sevoflurane may be a therapeutic alternative for painful CVU with a fast, intense, and long-lasting analgesic effect.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Adrian Imbernon-Moya, Francisco J. Ortiz-de Frutos, Monica Sanjuan-Alvarez, Isabel Portero-Sanchez, Raul Merinero-Palomares, Victoria Alcazar,